medigraphic.com
ISSN 1561-3186 (Electronic)

2019, Number 2

<< Back Next >>

Rev Acta Médica 2019; 20 (2)

Characterization of central nervous system tumors in patients cared for in Hermanos Ameijeiras Clinical-Surgical Hospital

Varona RLM, Sánchez RI, Cáceres LH, González GJ, Cruz PP, del Castillo CC, Estrada NY

Language: Spanish
References: 18
Page: 1-12
PDF size: 170.14 Kb.


ABSTRACT

Introduction: Central nervous system tumors are a diverse group of neoplasms which includes more than 60 histological types and currently represents 2.3% of all cancer-associated deaths.
Objective: To characterize tumors of the central nervous system according to histopathological subtype in a period of 10 years.
Method: A descriptive and retrospective study was carried out with 1092 cases of tumors of the central nervous system diagnosed at Hermanos Ameijeiras Clinical-Surgical Hospital from January 2006 to December 2015.
Results: The mean age was 49 years and the incidence was higher in the female sex (55.8%). Neuroepithelial tumors predominated (36.2%) followed by meningeal tumors (26.6%) and tumors of the sellar region (21%). The most frequent diseases were meningioma (26.2%) and pituitary adenomas (16.5%). The stage was determined in 786 primary tumors of the central nervous system. A higher prevalence (69.6%) of low-grade tumors (grade I and II) was shown with a mean age of 47 years and female predominance (61.8%), with meningioma as the most frequent disease (52.1%). Among the high-grade tumors, the mean age was 51 years, with no significant differences in the distribution between both sexes, and the most frequent disease was glioblastoma multiforme (58.6%).
Conclusions: The characterization of the present sample in consistent with other researches reviewed.


REFERENCES

  1. De Robles P, Fiest KM, Frolkis AD, Pringsheim T, Atta C, St Germaine-Smith C, et al. The worldwide incidence and prevalence of primary brain tumors: asystematic review and meta-analysis. Neuro Oncol. 2015;17(6):776-83. PubMed: PMID: 25313193.

  2. Quinn T, Ostrom MA, Haley G, Kromer C, Wolinsky Y, Kruchko C, et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009-2013. Neuro Oncol. 2016;18:1-75. PubMed: PMID: 26475809.

  3. Kleihues P, Burger PC, Scheithauer BW. The new WHO classification of brain tumours. Brain Pathol. 1993;3:255-68.

  4. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella Branger D, Cavenee WK, et al. The 2016 World health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol. 2016;131(6):803-20. PubMed: PMID: 27157931.

  5. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. PubMed: PMID: 25220842.

  6. Freddie B, Jacques F, Isabelle S. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancersin 185 countries. CA Cancer J Clin. 2018;68(6):394-24. PubMed: PMID: 30207593.

  7. Ostrom QT, Gittleman H, Farah P. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. Neuro Oncol. 2013;15:1-56.

  8. Cuba. Ministerio de Salud Pública. Anuario estadístico de salud 2013. La Habana. Dirección Nacional de Registros Médicos y Estadísticas; 2014 [acceso: 21/01/2019]. Disponible en: http://www.sld.cu/servicios/estadisticas

  9. Crocetti E, Trama A, Stiller C, Caldarella A, Soffietti R, Jaal J, et al. Epidemiology of glial and non-glial brain tumours in Europe. Eur J Cancer. 2012;48:1532-42.

  10. Chen L, Zou X, Wang Y. Central nervous systemtumors: a single center pathology review of 34,140 cases over 60 years. BMC Clin Pathol. 2013;13-14.

  11. Nakamura H, Makino K, Yano S. Brain tumor research group. Epidemiological study of primary intra-cranial tumors: a regional survey in Kumamoto prefecture insouthern Japan 20 year study. J Clin Oncol. 2011;16:314-21.

  12. Anaya Delgadillo G, de Juambelz Cisneros PP, Fernández Alvarado B, Pazos Gómez F, Velasco Torre A, Revuelta Gutierrez R. Prevalencia de tumores del sistema nervioso central y su identificación histológica en pacientes operados: 20 años de experiencia. Cir Cir. 2016 [acceso: 21/01/2019];84(6):447-53. Disponible en: https://www.elsevier.es/es-revista-cirugia-cirujanos-139-pdf-S0009741116000116

  13. Ramos Clason EC, Tuñón Pitalua MC, Rivas Muñoz FA, Veloza Cabrera LA. Tumores primarios del sistema nervioso central en Cartagena, 2001-2006. Rev Salud Pública. 2010;12 (2):257-67.

  14. Rigau V, Zouaoui S, Mathieu-Daudé H, Darlix A, Maran A, Trétarre B, et al. French brain tumor data base: 5-year histological results on 25 756 cases. Brain Pathol. 2011;21:633-44.

  15. McNeill KA. Epidemiology of brain tumors. Neurol Clin. 2016;34:981-98.

  16. Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL. Epidemiology of meningiomas post public law 107-206: the benign brain tumor cancer registries act. Cancer. 2015;121(14):2400-10. PubMed: PMID: 25872752.

  17. Contreras LE. Epidemiologia de tumores cerebrales. Rev Med Clin Condes. 2017 [acceso: 21/01/2019];28(3):332-8. Disponible en: http://epharma.elsevier.es/content/ lascondes_28_03/files/assets/common/downloads/lascondes_28_03.pdf

  18. Jiang H, Cui Y, Wang J, Lin S. Impact of epidemiological characteristics of supratentorial gliomas in adults brought about by the 2016 world health organization classification of tumors of the central nervous system. Oncotarget. 2017;8(12):20354-61. PubMed: PMID: 27888628.




2020     |     www.medigraphic.com